B lymphocytes in human subcutaneous adipose crown-like structures

Obesity

Volumn 20, Issue 7, 2012, Pages 1372-1378

  McDonnell, Marie E ^a   Ganley Leal, Lisa M ^a   Mehta, Ankeeta ^a   Bigornia, Sherman J ^a   Mott, Melanie ^a   Rehman, Qasim ^a   Farb, Melissa G ^a   Hess, Donald T ^b   Joseph, Lija ^b   Gokce, Noyan ^a   Apovian, Caroline M ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BOSTON MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; CD19 ANTIGEN; CD3 ANTIGEN; HEMOGLOBIN A1C; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; METFORMIN;

ABDOMINAL SUBCUTANEOUS FAT; ADULT; ARTICLE; B LYMPHOCYTE; CELL DENSITY; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; DISEASE ASSOCIATION; FEMALE; GLYCEMIC CONTROL; HOMEOSTASIS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INSULIN RESISTANCE; LYMPHOCYTE COUNT; LYMPHOCYTE FUNCTION; LYMPHOCYTE STRUCTURE; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; T LYMPHOCYTE;

ADULT; ANTIGENS, CD19; B-LYMPHOCYTES; BLOOD GLUCOSE; BODY MASS INDEX; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; IMMUNOHISTOCHEMISTRY; INSULIN RESISTANCE; MALE; OBESITY; OMENTUM; PREDICTIVE VALUE OF TESTS; SUBCUTANEOUS FAT;

RODENTIA;

EID: 84862888806     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1038/oby.2012.54     Document Type: Article

References (40)

1. McTigue K, Larson JC, Valoski A et al. Mortality and cardiac and vascular outcomes in extremely obese women. JAMA 2006;296:79-86.
2. Kaminski DA, Randall TD. Adaptive immunity and adipose tissue biology. Trends Immunol 2010;31:384-390.
3. Feuerer M, Herrero L, Cipolletta D et al. Lean, but not obese, fat is enriched for a unique population of regulatory T cells that affect metabolic parameters. Nat Med 2009;15:930-939.
4. Maury E, Ehala-Aleksejev K, Guiot Y et al. Adipokines oversecreted by omental adipose tissue in human obesity. Am J Physiol Endocrinol Metab 2007;293:E656-E665.
5. Moro K, Yamada T, Tanabe M et al. Innate production of T(H)2 cytokines by adipose tissue-associated c-Kit(+)Sca-1(+) lymphoid cells. Nature 2010;463:540-544.
6. Apovian CM, Bigornia S, Mott M et al. Adipose macrophage infiltration is associated with insulin resistance and vascular endothelial dysfunction in obese subjects. Arterioscler Thromb Vasc Biol 2008;28:1654-1659.
7. Permana PA, Menge C, Reaven PD. Macrophage-secreted factors induce adipocyte inflammation and insulin resistance. Biochem Biophys Res Commun 2006;341:507-514.
8. Strissel KJ, Stancheva Z, Miyoshi H et al. Adipocyte death, adipose tissue remodeling, and obesity complications. Diabetes 2007;56:2910-2918.
9. Bremer AA, Devaraj S, Afify A, Jialal I. Adipose tissue dysregulation in patients with metabolic syndrome. J Clin Endocrinol Metab 2011;96:E1782-E1788.
10. Wentworth JM, Naselli G, Brown WA et al. Pro-inflammatory CD11c+CD206+ adipose tissue macrophages are associated with insulin resistance in human obesity. Diabetes 2010;59:1648-1656.
11. Kling N, Fasshauer M, Dietrich A et al. Insulin-sensitive obesity. Am J Physiol Endocrinol Metab 2010;299:E506-E515.
12. Xu H, Barnes GT, Yang Q et al. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest 2003;112:1821-1830.
13. Lolme K, Duffaut C, Zakaroff-Girard A, Bouloumi A. Immune cells in adipose tissue: key players in metabolic disorders. Diabetes Metab 2011;37:283-290.
14. Kintscher U, Hartge M, Hess K et al. T-lymphocyte infiltration in visceral adipose tissue: a primary event in adipose tissue inflammation and the development of obesity-mediated insulin resistance. Arterioscler Thromb Vasc Biol 2008;28:1304-1310.
15. Duffaut C, Zakaroff-Girard A, Bourlier V et al. Interplay between human adipocytes and T lymphocytes in obesity: CCL20 as an adipochemokine and T lymphocytes as lipogenic modulators. Arterioscler Thromb Vasc Biol 2009;29:1608-1614.
16. Duffaut C, Galitzky J, Lafontan M, Bouloumi A. Unexpected trafficking of immune cells within the adipose tissue during the onset of obesity. Biochem Biophys Res Commun 2009;384:482-485.
17. Cinti S, Mitchell G, Barbatelli G et al. Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans. J Lipid Res 2005;46:2347-2355.
18. Nishimura S, Manabe I, Nagasaki M et al. CD8+ effector T cells contribute to macrophage recruitment and adipose tissue inflammation in obesity. Nat Med 2009;15:914-920.
19. Palming J, Gabrielsson BG, Jennische E et al. Plasma cells and Fc receptors in human adipose tissue-lipogenic and anti-inflammatory effects of immunoglobulins on adipocytes. Biochem Biophys Res Commun 2006;343:43-48.
20. Winer DA, Winer S, Shen L et al. B cells promote insulin resistance through modulation of T cells and production of pathogenic IgG antibodies. Nat Med 2011;17:610-617.
21. Jagannathan M, McDonnell M, Liang Y et al. Toll-like receptors regulate B cell cytokine production in patients with diabetes. Diabetologia 2010;53:1461-1471.
22. Doi H, Iyer TK, Carpenter E et al. Dysfunctional B-cell activation in cirrhosis due to hepatitis C infection associated with disappearance of CD27+ B-cell population. Hepatology 2012;55:709-719.
23. Onguru D, Liang Y, Griffith Q et al. Human schistosomiasis is associated with endotoxemia and Toll-like receptor 2-and 4-bearing B cells. Am J Trop Med Hyg 2011;84:321-324.
24. Major AS, Fazio S, Linton MF. B-lymphocyte deficiency increases atherosclerosis in LDL receptor-null mice. Arterioscler Thromb Vasc Biol 2002;22:1892-1898.
25. Liang Y, Ganley-Leal LM. A simple method for measuring human cell-bound IgE levels in whole blood. J Immunol Methods 2009;343:134-139.
26. Anolik J, Looney RJ, Bottaro A, Sanz I, Young F. Down-regulation of CD20 on B cells upon CD40 activation. Eur J Immunol 2003;33:2398-2409.
27. Binder CJ, Hartvigsen K, Chang MK et al. IL-5 links adaptive and natural immunity specific for epitopes of oxidized LDL and protects from atherosclerosis. J Clin Invest 2004;114:427-437.
28. Major TC, Liang L, Lu X, Rosebury W, Bocan TM. Extracellular matrix metalloproteinase inducer (EMMPRIN) is induced upon monocyte differentiation and is expressed in human atheroma. Arterioscler Thromb Vasc Biol 2002;22:1200-1207.
29. Virella G, Atchley D, Koskinen S, Zheng D, Lopes-Virella MF; DCCT/EDIC Research Group. Proatherogenic and proinflammatory properties of immune complexes prepared with purified human oxLDL antibodies and human oxLDL. Clin Immunol 2002;105:81-92.
30. Bennett WL, Maruthur NM, Singh S et al. Comparative effectiveness and safety of medications for type 2 diabetes: an update including new drugs and 2-drug combinations. Ann Intern Med 2010;154:602-613.
31. Jagannathan M, Hasturk H, Liang Y et al. TLR cross-talk specifically regulates cytokine production by B cells from chronic inflammatory disease patients. J Immunol 2009;183:7461-7470.
32. McDonnell M, Liang Y, Noronha A et al. Systemic Toll-like receptor ligands modify B-cell responses in human inflammatory bowel disease. Inflamm Bowel Dis 2011;17:298-307.
33. Vitseva OI, Tanriverdi K, Tchkonia TT et al. Inducible Toll-like receptor and NF-κB regulatory pathway expression in human adipose tissue. Obesity (Silver Spring) 2008;16:932-937.
34. Lee MJ, Wu Y, Fried SK. Adipose tissue remodeling in pathophysiology of obesity. Curr Opin Clin Nutr Metab Care 2010;13:371-376.
35. Pang C, Gao Z, Yin J et al. Macrophage infiltration into adipose tissue may promote angiogenesis for adipose tissue remodeling in obesity. Am J Physiol Endocrinol Metab 2008;295:E313-E322.
36. O'Rourke RW, White AE, Metcalf MD et al. Hypoxia-induced inflammatory cytokine secretion in human adipose tissue stromovascular cells. Diabetologia 2011;54:1480-1490.
37. DeFronzo RA, Barzilai N, Simonson DC. Mechanism of metformin action in obese and lean noninsulin-dependent diabetic subjects. J Clin Endocrinol Metab 1991;73:1294-1301.
38. Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HA. 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med 2008;359:1577-1589.
39. Zang M, Zuccollo A, Hou X et al. AMP-activated protein kinase is required for the lipid-lowering effect of metformin in insulin-resistant human HepG2 cells. J Biol Chem 2004;279:47898-47905.
40. Solano ME, Sander V, Wald MR, Motta AB. Dehydroepiandrosterone and metformin regulate proliferation of murine T lymphocytes. Clin Exp Immunol 2008;153:289-296.